Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Shelby Sullivan MD

Shelby Sullivan MD

Assistant Professor of Medicine, Department of Medicine, Division of Gastroenterology; Washington University School of Medicine, St. Louis, Missouri

Dr. Sullivan is an Assistant Professor of Medicine at Washington University School of Medicine since July of 2007. She graduated from Washington University School of Medicine in 2001, and completed her internal medicine residency there in 2004. Dr. Sullivan also pursued training in Gastroenterology as a fellow in GI at Washington University School of Medicine, which she completed in June of 2007. She is currently pursuing her Masters of Science in Clinical Investigation at Washington University School of Medicine.

Dr. Sullivan is an ad hoc reviewer for American Journal of Clinical Nutrition, European Journal of Nutrition, Obesity, and PLOS ONE. She is currently a member of the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and The Obesity Society. 

She has written chapters and editorial reviews, co-authored and authored abstracts and peer-reviewed publications, and participates in lectureships. 


Dr. Sullivan was a consultant to Aspire Bariatrics (ended 11/2018), USGI Medical (ended 12/2018), GI Dynamics (ended 7/2019), Spatz FGIA (ended 9/2018), Phenomix Sciences (ended 5/2020) and is currently a consultant to Allurion Technologies, Elira Therapeutics, Endo Tools Therapeutics, Nitinotes Surgical, and Obalon Therapeutics. Dr. Sullivan has performed contracted research for Aspire Bariatrics (ongoing), Obalon Therapeutics (ongoing), Allurion Technologies (ended 12/2019), Elira Therapeutics (ended 5/2019) Finch Therapeutics (ongoing) and ReBiotix (ongoing). Dr. Sullivan has received stock warrants from Elira Therapeutics.